Quality Investigations, CAPAs & Change Controls

We transform Quality Investigations, CAPAs, and Change Controls from compliance bottlenecks into business enablers by cutting cycle times, clearing backlogs, reducing human error, eliminating repeat issues and deviations, and building regulatory agency-ready processes that save time, lower cost of quality, and protect supply continuity.

Our Services

Quality Investigations, Change Controls, and CAPAs are where companies either build credibility or lose it with regulators. We help pharmaceutical and biopharmaceutical organizations redesign these processes and enable them to move faster, reduce human errors, eliminate repeat deviations, and strengthen compliance confidence. Our solutions shorten cycle times, cut investigation backlogs, and eliminate waste while ensuring actions stick and risks stay controlled.

• Investigation Process Design – Faster, standardized workflows that reduce cycle time and withstand regulatory scrutiny.
• Training & Capability Building – Teams trained to close investigations quickly, accurately, and consistently.
• Backlog & Complaint Reduction – Immediate remediation of investigation backlogs and complaint spikes to free resources and restore compliance confidence.
• Change Control Process Design – Risk-based, streamlined controls that enable agility without compromising compliance.
• Root Cause Analysis (RCA) – Precision problem-solving that fixes issues once, avoiding costly recurrences.
• Human Error Reduction – Practical strategies to minimize operator-driven deviations and strengthen right-first-time execution.
• CAPA Effectiveness Verification – Evidence-based checks to prove actions worked and prevent repeat inspections.
• Trending & Risk Mitigation – Early-warning insights to catch problems before they become recalls, delays, or audit findings.
• Predictive Deviation Analytics – Trending that anticipates deviations and recurrence rather than reporting them after closure.

We don’t just “fix” investigations. At Biostrategenix, we help you turn them into a business advantage: faster resolutions, lower cost of quality, and greater trust with regulators and patients.

How This Is Usually Scoped

Investigation and CAPA work runs as a Focused Engagement — a single workstream delivered by the principal. Where a backlog sits inside a regulatory commitment, it runs as part of a Program Engagement. Either way it begins with a Rapid Diagnostic.

Related reading from Decoded

• “Human Error” Is Not a Root Cause: What FDA’s Human Factors Guidance Tells Pharma
• The Real Cost of Different Quality Control Rules in Global Pharmaceuticals
• FDA Computer Software Assurance: What Quality Teams Need to Know in 2025